{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T17:29:49Z","timestamp":1772040589693,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,9]]},"DOI":"10.7759\/cureus.20303","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T16:37:23Z","timestamp":1639067843000},"source":"Crossref","is-referenced-by-count":8,"title":["Healing of Severe Herpes Zoster Ophthalmicus Within a Few Days: An Autobiographical Case Report"],"prefix":"10.7759","author":[{"given":"Tibor","family":"Bakacs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1086\/510206","article-title":"Recommendations for the management of herpes zoster","volume":"44","author":"Dworkin RH","year":"2007","unstructured":"Dworkin RH, Johnson RW, Breuer J, et al.. Recommendations for the management of herpes zoster. Clin Infect Dis. 2007, 44:S1-26. 10.1086\/510206","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1262-8","article-title":"Annual incidence rates of herpes zoster among an immunocompetent population in the United States","volume":"15","author":"Johnson BH","year":"2015","unstructured":"Johnson BH, Palmer L, Gatwood J, Lenhart G, Kawai K, Acosta CJ. Annual incidence rates of herpes zoster among an immunocompetent population in the United States. BMC Infect Dis. 2015, 15:502. 10.1186\/s12879-015-1262-8","journal-title":"BMC Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2990.2011.01167.x","article-title":"Review: the neurobiology of varicella zoster virus infection","volume":"37","author":"Gilden D","year":"2011","unstructured":"Gilden D, Mahalingam R, Nagel MA, Pugazhenthi S, Cohrs RJ. Review: the neurobiology of varicella zoster virus infection. Neuropathol Appl Neurobiol. 2011, 37:441-63. 10.1111\/j.1365-2990.2011.01167.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"ref4","article-title":"Herpes zoster clinical presentation","volume":"2","author":"Janniger CK","year":"2021","unstructured":"Janniger CK, Eastern JS, Hospenthal DR. Herpes zoster clinical presentation. Medscape. 2021, 2:2-4.","journal-title":"Medscape"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-200101","article-title":"Herpes zoster on the face in the elderly","volume":"2014","author":"Nair P","year":"2014","unstructured":"Nair P, Gharote H, Singh P, Jain-Choudhary P. Herpes zoster on the face in the elderly. BMJ Case Rep. 2014, 2014:bcr2013200101. 10.1136\/bcr-2013-200101","journal-title":"BMJ Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2174\/1871526519666190405140858","article-title":"Therapeutic exploitation of viral interference","volume":"20","author":"Kovesdi I","year":"2020","unstructured":"Kovesdi I, Bakacs T. Therapeutic exploitation of viral interference. Infect Disord Drug Targets. 2020, 20:423-32. 10.2174\/1871526519666190405140858","journal-title":"Infect Disord Drug Targets"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s41124-017-0028-x","article-title":"Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needs","volume":"3","author":"Bakacs T","year":"2018","unstructured":"Bakacs T, Safadi R, Kovesdi I. Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needs. Hepatol Med Policy. 2018, 3:2. 10.1186\/s41124-017-0028-x","journal-title":"Hepatol Med Policy"},{"key":"ref8","article-title":"Oro-facial herpes zoster: a case report with a detailed review of literature","volume":"4","author":"Vineet DA","year":"2013","unstructured":"Vineet DA, Mithra R, Baskaran P, Mishra S. Oro-facial herpes zoster: a case report with a detailed review of literature. Oral Maxillofac Pathol J. 2013, 4:346-50.","journal-title":"Oral Maxillofac Pathol J"},{"key":"ref9","article-title":"Treatment of herpes zoster","volume":"54","author":"Opstelten W","year":"2008","unstructured":"Opstelten W, Eekhof J, Neven AK, Verheij T. Treatment of herpes zoster. Can Fam Physician. 2008, 54:373-7.","journal-title":"Can Fam Physician"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/35099560","article-title":"Recognition of double-stranded RNA and activation of NF-kappaB by toll-like receptor 3","volume":"413","author":"Alexopoulou L","year":"2001","unstructured":"Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by toll-like receptor 3. Nature. 2001, 413:732-8. 10.1038\/35099560","journal-title":"Nature"},{"key":"ref11","article-title":"Interference between human hepatitis A virus and an attenuated apathogenic avian virus","volume":"31","author":"Csatary LK","year":"1984","unstructured":"Csatary LK, Kasza L, Massey RJ. Interference between human hepatitis A virus and an attenuated apathogenic avian virus. Acta Microbiol Hung. 1984, 31:153-8.","journal-title":"Acta Microbiol Hung"},{"key":"ref12","article-title":"Preliminary report of a controlled trial of MTH-68\/B virus vaccine treatment in acute B and C hepatitis: a phase II study","volume":"18","author":"Csatary LK","year":"1998","unstructured":"Csatary LK, Telegdy L, Gergely P, Bodey B, Bak\u00e1cs T. Preliminary report of a controlled trial of MTH-68\/B virus vaccine treatment in acute B and C hepatitis: a phase II study. Anticancer Res. 1998, 18:1279-82.","journal-title":"Anticancer Res"},{"key":"ref13","article-title":"Successful treatment of decompensated chronic viral hepatitis by bursal disease virus vaccine","volume":"19","author":"Csatary LK","year":"1999","unstructured":"Csatary LK, Schnabel R, Bak\u00e1cs T. Successful treatment of decompensated chronic viral hepatitis by bursal disease virus vaccine. Anticancer Res. 1999, 19:629-33.","journal-title":"Anticancer Res"},{"key":"ref14","article-title":"Adverse effects of interferon treatment","author":"Aul C","year":"1997","unstructured":"Aul C, Gattermann N, Germing U, Heyll A. Adverse effects of interferon treatment. Interferons. Springer, Berlin, Heidelberg, Germany; 1997. 1:250-266."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.2830","article-title":"Effective multiple oral administration of reverse genetics engineered infectious bursal disease virus in mice in the presence of neutralizing antibodies","volume":"17","author":"Horny\u00e1k \u00c1","year":"2015","unstructured":"Horny\u00e1k \u00c1, Lipinski KS, Bakonyi T, et al.. Effective multiple oral administration of reverse genetics engineered infectious bursal disease virus in mice in the presence of neutralizing antibodies. J Gene Med. 2015, 17:116-31. 10.1002\/jgm.2830","journal-title":"J Gene Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202002.0147.v4","article-title":"The clinically validated viral superinfection therapy (SIT) platform technology could cure early cases of COVID-19 disease [PREPRINT]","author":"Kovesdi IS","year":"2021","unstructured":"Kovesdi IS, Slavin S, Renz W. The clinically validated viral superinfection therapy (SIT) platform technology could cure early cases of COVID-19 disease [PREPRINT]. Preprints. 2021, 10.20944\/preprints202002.0147.v4","journal-title":"Preprints"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-017-1351-y","article-title":"How to choose the best journal for your case report","volume":"11","author":"Rison RA","year":"2017","unstructured":"Rison RA, Shepphird JK, Kidd MR. How to choose the best journal for your case report. J Med Case Rep. 2017, 11:198. 10.1186\/s13256-017-1351-y","journal-title":"J Med Case Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/14653240510027136","article-title":"History of the clinical use of umbilical cord blood hematopoietic cells","volume":"7","author":"Gluckman E","year":"2005","unstructured":"Gluckman E, Rocha V. History of the clinical use of umbilical cord blood hematopoietic cells. Cytotherapy. 2005, 7:219-27. 10.1080\/14653240510027136","journal-title":"Cytotherapy"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-492231","article-title":"Antibody-modified T cells: CARs take the front seat for hematologic malignancies","volume":"123","author":"Maus MV","year":"2014","unstructured":"Maus MV, Grupp SA, Porter DL, June CH. Antibody-modified T cells: CARs take the front seat for hematologic malignancies. Blood. 2014, 123:2625-35. 10.1182\/blood-2013-11-492231","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/78051-healing-of-severe-herpes-zoster-ophthalmicus-within-a-few-days-an-autobiographical-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:32:45Z","timestamp":1707507165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/78051-healing-of-severe-herpes-zoster-ophthalmicus-within-a-few-days-an-autobiographical-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,9]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.20303","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,9]]}}}